DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · DICE · as of Jun 9, 2026
Activity summary
Buy transactions
7
P-Purchase only
Sell transactions
13
12 Months
Buy/Sell ratio
0.54
Buy/Sell (by trades)
Overall sentiment
DICE Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
DICE insider buying and selling by quarter
DICE insider selling · DICE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
DICE executive sell shares · DICE board member insider trading · DICE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 9, 2023 | RA CAPITAL MANAGEMENT, L.P. | Other | 786,407 | $79 | Form 4 |
| Aug 9, 2023 | TETLOW SHARON Director | Other | 49,841 | $5 | Form 4 |
| Aug 9, 2023 | Scopa James Paul Director | Other | 25,722 | $3 | Form 4 |
| Aug 9, 2023 | Robertson Scott M. CFO & CBO | Other | 198,000 | $20 | Form 4 |
| Aug 9, 2023 | SCHELLER RICHARD H Director | Other | 8,427 | $1 | Form 4 |
| Aug 9, 2023 | Timothy Lu CMO | Other | 152,285 | $15 | Form 4 |
| Aug 9, 2023 | Judice Kevin CEO · Director | Other | 799,685 | $80 | Form 4 |
| Aug 9, 2023 | Jacobsen John R. CSO | Other | 147,497 | $15 | Form 4 |
| Aug 2, 2023 | Scopa James Paul Director | Gift | 220 | — | Form 4 |
| Aug 2, 2023 | Scopa James Paul Director | Gift | 2,200 | — | Form 4 |
| Jul 18, 2023 | Scopa James Paul Director | Gift | 2,200 | — | Form 4 |
| Jul 11, 2023 | Scopa James Paul Director | Gift | 300 | — | Form 4 |
| Jun 22, 2023 | Northpond Ventures GP, LLC 10 percent owner | Sale | 1,969,368 | $91.58M⚡ | Form 4 |
| Jun 22, 2023 | Northpond Ventures GP, LLC 10 percent owner | Sale | 523,503 | $24.34M⚡ | Form 4 |
| Jun 1, 2023 | Jacobsen John R. CSO | Sale | 14,307 | $434K | Form 4 |
| Jun 1, 2023 | Jacobsen John R. CSO | Sale | 4,443 | $139K | Form 4 |
| May 5, 2023 | SCHELLER RICHARD H Director | Sale | 84,097 | $3.24M⚡ | Form 4 |
| May 3, 2023 | Robertson Scott M. CFO & CBO | Sale | 18,750 | $685K | Form 4 |
| May 3, 2023 | Timothy Lu CMO | Sale | 10,000 | $365K | Form 4 |
| May 3, 2023 | Judice Kevin CEO · Director | Sale | 13,698 | $500K | Form 4 |
| May 1, 2023 | Scopa James Paul Director | Gift | 6,923 | — | Form 4 |
| May 1, 2023 | Scopa James Paul Director | Gift | 6,923 | — | Form 4 |
| Apr 18, 2023 | Jacobsen John R. CSO | Sale | 16,392 | $493K | Form 4 |
| Mar 31, 2023 | Jacobsen John R. CSO | Sale | 773 | $23K | Form 4 |
| Mar 30, 2023 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | 195,997 | $5.63M⚡ | Form 4 |
Northpond Ventures GP, LLC
10 percent owner
Date
Jun 22
Shares
1,969,368
Price
$46.50
Value
$91.58M ⚡
Northpond Ventures GP, LLC
10 percent owner
Date
Jun 22
Shares
523,503
Price
$46.50
Value
$24.34M ⚡
RA CAPITAL MANAGEMENT, L.P.
Director
Date
Mar 30
Shares
195,997
Price
$28.74
Value
$5.63M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About DICE insider trading
DICE insider trades
DICE Therapeutics, Inc. (DICE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DICE. Over the past 12 months, 0 insiders have filed transactions with the SEC. DICE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For DICE Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
DICE insider trading · 5 questionsThe insiders of DICE Therapeutics, Inc. (DICE) include executives and directors such as DICE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026